tbuckley/cabot-search huggingface dataset:
Kickoff for AMA's new PMI program
Authors: Phil Gunby
Journal: JAMA (1982)

The American Medical Association's Patient Medication Instruction (PMI) program is being introduced to physicians this month (see "Open Letter," page 1015). Within the next few weeks, approximately 400,000 practicing physicians (MDs and DOs) will receive an introductory packet that explains the program and tells how to order instruction sheets that can be given to patients when drugs are prescribed. Each PMI is a single sheet, 14×21.5 cm (5.5×8.5 in) in size, printed on the front and back, with easy-to-understand information about the drug class or particular drug (the generic name is used) being prescribed. They are bound in pads of 100 sheets and will be updated periodically when new information about the medication becomes available. Physicians will pay only for postage and handling, which amount to about $.50 per 100-sheet pad, but orders must be for lots of 10 pads or more. An order form also will be available in
Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine
Authors: K. A. Dillon
Journal: JAMA (1997)

<h3>In Reply.</h3> —The suggestion by Dr Clayton and others regarding the use of EPS-sparing antipsychotic drugs for the treatment of delusions of parasitosis is a good idea that needs to be evaluated clinically. If these medications do work well for delusions of parasitosis, they can certainly replace pimozide as the treatment of choice. However, these EPS-sparing antipsychotic medications may not work as well as pimozide. This possibility arises because there is something unique about pimozide compared with the other antipsychotic agents, and this uniqueness may be responsible for pimozide's particular efficacy for this condition: pimozide has great efficacy for formication (crawling, biting, and stinging sensations).<sup>1</sup>In Europe, it was found that there are only 2 antipsychotic medications that have profound effect on formication: one is pimozide and the other is flusipilene, a long-acting antipsychotic medication not available in the United States.<sup>2</sup>Both of these medications are unique in that they
Rheumaprobleme
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
French comment on article Incomplete resection rate of cold snare polypectomy: a prospective single-arm observational study1 Évaluation du taux de résections incomplètes après polypectomie à l’anse froide: une étude prospective observationnelle monocentrique
Journal: Endoscopy (2017)

Introduction: La polypectomie à l’anse froide est considérée comme une technique de choix pour la résection des polypes colorectaux infracentimétriques. Cette étude prospective observationnelle à un seul bras avait pour objectif de déterminer le taux de polypectomies à l’anse froide incomplètes pour des polypes infracentimétriques néoplasiques dans un centre japonais.
Interstitial and coxsackievirus B myocarditis in infants and children. A comparative histologic and immunofluorescent study of 50 autopsied hearts
Authors: G. E. Burch
Journal: JAMA (1968)

Fifty hearts of infants and children were collected at routine autopsies and were surveyed by means of routine histologic techniques and immunofluorescent antibody staining methods. Twenty-nine hearts had interstitial myocarditis with varying degree of myocardial damage. Seventeen had interstitial reactions with an increase in cellularity and with patchy edema. Coxsackievirus B antigens were found in 12 of these hearts. The high incidence of coxsackievirus B antigen in the myocardium of the infants and children is possibly related to the "myocarditis," labeled variously as Fiedler's, idiopathic, interstitial, isolated, or aseptic myocarditis or chronic rheumatic heart disease. The common occurrence of clinically occult coxsackievirus B infection may possibly be related to the etiology of still-births, congenital anomalies, and sudden, unexpected deaths in infancy and childhood. The need for better diagnostic virological facilities in clinical practice is evident from these studies.
Laryngeal Vertigo
Authors: H. Clark
Journal: BMJ (1952)

BJAL vaccinated prior to emigration.Our.patient's vaccinia com- menced on the eczematous areas and was generalized on admission.Virus studies confirmed the diagnosis." Aureomycin " had no effect on the viraemia.On the fifth day the temperature had risen steadily to 105' F. (40.5'C.), the pulse rate was extremely rapid, and the child's general condition was very grave.A highly concerjtrated post- vaccinial gamma globulin obtained from the Public Health Laboratory, Colindale, was now given.Within 12 hours there was for the first time a remission of the temperature, a slowing of the pulse rate, and an improvement in the general condition.This remission was not fully maintained, but ultimately the child survived.We make no claim for this serum, which was given so late and in only one case.In fut we used the only sample obtainable.The mortality in this variety of Kaposi's varicelliform eruption is so high, however, that we suggest a trial of the immediate use of such a serum in future caEes.-Weare, etc.,
Smoking Prevention/Cessation Drive Can Parallel Continuing Tobacco-Effects Research, NCI Says
Journal: JAMA (1987)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache
Authors: J. Jones
Journal: JAMA (1989)

In a prospective, randomized, double-blind clinical trial, intravenous prochlorperazine edisylate (Compazine Edisylate) was compared with a placebo in the treatment of severe headaches. Eighty-two adult patients with vascular or tension-type headaches were identified at the time of presentation to one of three participating emergency departments. After the patient gave informed consent, a 2-mL intravenous injection of sterile saline solution or prochlorperazine edisylate (10 mg) was given to each patient at the time of randomization. The treatment groups were similar with regard to age, sex, and type and duration of headache. Within 60 minutes after injection, 74% (31/42) of those who received prochlorperazine had complete relief; 14% (6/42) of the patients had partial relief. Overall, there was complete or partial relief of pain in 88% (37/42) of the drug group and in 45% (18/40) of the placebo group. This difference was statistically significant using χ<sup>2</sup>analysis. Adverse effects were minimal; one patient experienced asymptomatic orthostatic hypotension. These results suggest that intravenous prochlorperazine is an effective treatment for patients with severe vascular or tension headaches who present to the emergency department. (<i>JAMA</i>1989;261:1174-1176)
The Medical Register of New York, New Jersey and Connecticut, 1889-90.
Journal: JAMA (1889)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
How does a diagnosis of thin cutaneous malignant melanoma affect survival rates?
Journal: British Journal of Dermatology (2021)

Cutaneous malignant melanoma is a type of skin cancer that you can die from. The number of patients being diagnosed with malignant melanoma of the skin is rising in most countries. About 4000 patients were diagnosed in Sweden in 2018. The risk of dying from cutaneous melanoma is very much dependent on the thickness of melanoma, a measure given by the pathologist after removing the melanoma. The risk of dying increases with increasing thickness. Most patients who are diagnosed with cutaneous melanoma will have thin melanomas, i.e. 1 mm or thinner.
Educating Physicians in Home Health Care
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cellular architecture and intercellular communication in rat liver
Authors: J. P. Revel
Journal: JAMA (1981)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
National Institutes of Health Consensus Conference. Surgery for epilepsy
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ORGAN STIMULATION BY THE ROENTGEN RAY
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Eleven years of community-based directly observed therapy for tuberculosis
Authors: C. P. Chaulk
Journal: JAMA (1995)

<h3>Objective.</h3> —To evaluate community-based directly observed therapy (DOT) for tuberculosis (TB) control. <h3>Design.</h3> —Ecological study. <h3>Methods.</h3> —Three comparisons were made in this descriptive study. (1) An 11-year retrospective comparison of TB case rates, sputum conversion rates (SCRs), rates of therapy completion, and confounding factors (acquired immunodeficiency syndrome [AIDS], immigration, unemployment, and poverty) in Baltimore, Md, with those of the five major US cities having the highest TB incidence in 1981 but which did not have comprehensive DOT programs. (2) An 11-year trend of TB in Baltimore and the 19 major US cities with the highest TB incidence in 1981. (3) A 7-year trend in TB in both city groups between 1985 and 1992. <h3>Setting.</h3> —Twenty US metropolitan cities with more than 250 000 residents. <h3>Results.</h3> —Since 1981, Baltimore experienced the greatest decline in TB incidence (35.6 cases per 100000 population, 1981; 17.2 cases per 100000 population, 1992 [-51.7%]), and city rank for TB (sixth in 1981,28th in 1992). Conversely, the average incidence of TB increased 2.1% in the five-city cohort and increased 1.8% in the 19-city cohort. Since 1985, TB incidence increased 35.3% in the five-city cohort and 28.5% in the 19-city cohort, but declined 29.5% in Baltimore. From 1986 through 1992, Baltimore's DOT-managed cases had the highest annual SCRs at 3 months (mean, 90.7%), and the highest completion rates for standard anti-TB therapy (mean, 90.1%) when compared with the five cities. These trends could not be attributed to differentials in AIDS, immigration, poverty, or unemployment. Increasingly, more Baltimore cases were treated under DOT (86.5%, 1993) overtime. Disease relapse rates remained low, even among HIV-infected patients. Within Baltimore, the documented SCR was significantly higher among DOT-managed cases compared with non—DOT-managed cases (<i>P</i>&lt;.05); multidrug resistance remains rare (0.57%). Within Maryland, Baltimore accounted for 44.4% of all TB cases in 1981, compared with 28.7% in 1992 (<i>P</i>&lt;.001). <h3>Conclusions.</h3> —In contrast to the national TB upswing during the 1980s, Baltimore experienced a substantial decline in TB following implementation of community-based DOT, despite highly prevalent medicosocial risk factors. Directly observed therapy facilitated high treatment completion rates and bacteriologic evidence of cure. Directly observed therapy could help reduce TB incidence in the United States, particularly in cities with high case rates. (<i>JAMA</i>. 1995;274:945-951)
THE ASSOCIATION OF MILITARY SURGEONS OF THE UNITED STATES.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Healthy People 2000
Journal: Environmental Health Perspectives (1993)

Until recently, says Plewa, the litera- ture in this area has suggested that bound residues exhibit little bioavailability when consumed by animals, so the "traditional idea is don't worry about them; it can't hurt you."However, recent studies dem- onstrated that scientists may be severely underestimating the bioavailability of these residues, with implications for risk assess- ment.Studies published in the Journal of Agricultural and Food Chemistry showed 66% of chloroaniline (a model xenobiot- ic)-lignin metabolites were released as simple chloroaniline derivatives after passage through the rat gastrointestinal tract, and 11-20% of bound residues was released from 3,4-dichloroaniline-lignin isolated from wheat plants that were fed to rats and lambs.According to Plewa, these studies indicate that "the toxicity [of the metabo- lite] could be released.It isn't just tied up and disappears."There appears to be a wide range in the bioavailability of xenobi- otics bound to insoluble plant fractions.This range in bioavailability raises questions that may have great impact in the future for environmental toxicology.Plewa says that plants are being bombard- ed with materials.What isn't known is the capacity of plants to serve as a sink.Is it possible to saturate this sink so that plants cannot further absorb and metabolize chemicals to stable, insoluble forms, and if so, will plants then release what they can't absorb, damaging the biosphere?In addi- tion, Plewa states that if current risk assessments are based on the amount of residue that is not bound, then a change in that estimate could have a radical effect: "You don't need to alter too much of the equa- tion before it shifts the risk assessment."
Prediction of Contaminant Retention and Transport in Soils Using Kinetic Multireaction Models
Authors: H. M. Selim
Journal: Environmental Health Perspectives (1989)

Mathematical models that describe the retention reactions of contaminants in the soil system are presented. Single and multireaction-type models for simultaneous retention and transport in the soil profile are discussed. Single retention models are classified into two types: equilibrium and kinetic models. Emphasis is given to the nonlinearity and kinetic behavior of solute retention processes in soils. Two-site models that include the equilibrium-kinetic types as well as the fully kinetic type are also examined. A multireaction-type model is also presented, which includes reversible and irreversible retention processes of the equilibrium and kinetic types. Advantages of the multireaction approach over the single or two-site models are discussed. The predictive capability of the two-site model and the multireaction model for their description of experimental results for phosphorus and two heavy metals (Cd and Cr) are examined.